D-Index & Metrics Best Publications

José Alexandre de Souza Crippa

Universidade de São Paulo
Brazil

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 81 Citations 21,961 427 World Ranking 11467 National Ranking 28

Overview

What is he best known for?

The fields of study José Alexandre de Souza Crippa is best known for:

Antidepressant
Serotonin
Fluoxetine

With his scientific publications, his incorporates both Psychiatry and Anesthesia. With his scientific publications, his incorporates both Anesthesia and Psychiatry. His Internal medicine study frequently draws parallels with other fields, such as Hippocampus. His Hippocampus study frequently draws connections to other fields, such as Internal medicine. While working in this field, José Alexandre de Souza Crippa studies both Cannabis and Cannabinoid. He applies his multidisciplinary studies on Cannabinoid and Cannabis in his research. He integrates many fields, such as Cannabidiol and Tetrahydrocannabinol, in his works. He incorporates Tetrahydrocannabinol and Cannabidiol in his studies. His Receptor study frequently links to adjacent areas such as Anxiolytic.

His most cited work include:

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing (384 citations)
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent (370 citations)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network (271 citations)

What are the main themes of his work throughout his whole career to date

José Alexandre de Souza Crippa incorporates Psychiatry and Anesthesia in his studies. José Alexandre de Souza Crippa integrates Anesthesia with Psychiatry in his research. His Internal medicine study often links to related topics such as Anxiolytic. His Anxiolytic study frequently draws connections to other fields, such as Internal medicine. He merges Anxiety with Social anxiety in his study. In his papers, José Alexandre de Souza Crippa integrates diverse fields, such as Social anxiety and Anxiety. José Alexandre de Souza Crippa connects Cannabis with Cannabidiol in his study. He performs integrative study on Cannabidiol and Cannabis in his works. José Alexandre de Souza Crippa integrates Pharmacology and Biochemistry in his studies.

José Alexandre de Souza Crippa most often published in these fields:

Psychiatry (78.31%)
Internal medicine (48.19%)
Anxiety (40.96%)

What were the highlights of his more recent work (between 2019-2022)?

Psychiatry (100.00%)
Internal medicine (100.00%)
Cannabidiol (80.00%)

In recent works José Alexandre de Souza Crippa was focusing on the following fields of study:

His research on Psychiatry frequently connects to adjacent areas such as Severity of illness. His research on Severity of illness often connects related areas such as Psychiatry. Internal medicine is closely attributed to Logistic regression in his study. In most of his Logistic regression studies, his work intersects topics such as Internal medicine. José Alexandre de Souza Crippa performs integrative study on Cannabidiol and Endocannabinoid system. He merges Endocannabinoid system with Cannabinoid in his study. In his works, he conducts interdisciplinary research on Cannabinoid and Cannabis. He brings together Cannabis and Cannabidiol to produce work in his papers. As part of his studies on Pathology, he frequently links adjacent subjects like Protective factor.

Between 2019 and 2022, his most popular works were:

Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (18 citations)
Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes (14 citations)
Risk and Protective Factors for the Mental Health of Brazilian Healthcare Workers in the Frontline of COVID-19 Pandemic (14 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Sagnik Bhattacharyya;Paul D Morrison;Paolo Fusar-Poli;Paolo Fusar-Poli;Rocio Martin-Santos.
Neuropsychopharmacology (2010)

721 Citations

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Mateus M. Bergamaschi;Regina Helena Costa Queiroz;Regina Helena Costa Queiroz;Marcos Hortes Nisihara Chagas;Marcos Hortes Nisihara Chagas;Danielle Chaves Gomes De Oliveira;Danielle Chaves Gomes De Oliveira.
Neuropsychopharmacology (2011)

700 Citations

Safety and side effects of cannabidiol, a Cannabis sativa constituent.

Mateus Machado Bergamaschi;Regina Helena Costa Queiroz;Antonio Waldo Zuardi;José Alexandre de Souza Crippa.
Current Drug Safety (2011)

539 Citations

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

A.W. Zuardi;J.A.S. Crippa;J.E.C. Hallak;F.A. Moreira.
Brazilian Journal of Medical and Biological Research (2006)

531 Citations

Cannabis and anxiety: a critical review of the evidence

José Alexandre Crippa;Antonio Waldo Zuardi;Rocio Martín-Santos;Sagnik Bhattacharyya.
Human Psychopharmacology-clinical and Experimental (2009)

520 Citations

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Paolo Fusar-Poli;José Alexandre de Souza Crippa;Sagnik Bhattacharyya;Stefan J. Borgwardt.
Archives of General Psychiatry (2009)

506 Citations

Alcohol Use Disorders Identification Test (AUDIT): an updated systematic review of psychometric properties

Carolina de Meneses-Gaya;Antonio Waldo Zuardi;Sonia Regina Loureiro;José Alexandre S. Crippa.
Psychology and Neuroscience (2009)

490 Citations

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report:

José Alexandre S Crippa;Guilherme Nogueira Derenusson;Thiago Borduqui Ferrari;Lauro Wichert-Ana.
Journal of Psychopharmacology (2011)

469 Citations

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report

Flávia de L. Osório;Rafael F. Sanches;Ligia R. Macedo;Rafael G. dos Santos.
Revista Brasileira de Psiquiatria (2015)

428 Citations

Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings

Albert Batalla;Sagnik Bhattacharyya;Murat Yucel;Paolo Fusar-Poli.
PLOS ONE (2013)

418 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for José Alexandre de Souza Crippa